Does Fruquintinib work?

Fruquintinib (Fruquintinib) is an oral, small molecule angiogenesis inhibitor mainly used to treat patients with advanced colorectal cancer. It inhibits the formation of new blood vessels in tumors by inhibiting the activity of vascular endothelial growth factor receptor (VEGFR), thereby achieving the purpose of inhibiting tumor growth. According to the results of multiple clinical studies, fruquintinib has certain efficacy in the treatment of patients with advanced colorectal cancer. In some clinical trials, fruquintinib monotherapy can significantly prolong patient survival and improve quality of life in patients with advanced colorectal cancer. In addition, fruquintinib can be used in combination with other chemotherapy drugs to further improve the efficacy.